Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

[1]  Lisa A. Mullen,et al.  High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy , 2022, Breast Cancer Research and Treatment.

[2]  G. Tse,et al.  Papillary lesions of the breast - review and practical issues. , 2022, Seminars in diagnostic pathology.

[3]  C. Cullinane,et al.  The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): A systematic review & meta-analysis. , 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  Ji-Young Kim,et al.  Additional Excision Biopsy in Patients With Atypical Ductal Hyperplasia at Ultrasound-guided Vacuum-assisted Breast Biopsy , 2022, AntiCancer Research.

[5]  C. Kuzmiak,et al.  Upgrade rate of percutaneously diagnosed pure flat epithelial atypia: systematic review and meta-analysis of 1,924 lesions , 2022, Journal of osteopathic medicine.

[6]  M. Bahl,et al.  Management of Architectural Distortion on Digital Breast Tomosynthesis With Nonmalignant Pathology at Biopsy. , 2022, AJR. American journal of roentgenology.

[7]  D. Ross,et al.  Papillary Neoplasms of the Breast: Diagnostic Features and Molecular Insights. , 2022, Surgical pathology clinics.

[8]  G. Baird,et al.  Malignancy Upgrade Rates of Radial Sclerosing Lesions at Breast Cancer Screening. , 2021, Radiology. Imaging cancer.

[9]  F. Sardanelli,et al.  B3 Lesions at Vacuum-Assisted Breast Biopsy under Ultrasound or Mammography Guidance: A Single-Center Experience on 3634 Consecutive Biopsies , 2021, Cancers.

[10]  U. Güth,et al.  Factors Indicating Surgical Excision in Classical Type of Lobular Neoplasia of the Breast , 2021, Breast Care.

[11]  E. Rutgers,et al.  Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  T. Fehm,et al.  Malignancy Rate and Malignancy Risk Assessment in Different Lesions of Uncertain Malignant Potential in the Breast (B3 Lesions): An Analysis of 192 Cases from a Single Institution , 2021, Breast Care.

[13]  A. Tardivon,et al.  Clinical management of atypical ductal hyperplasia on vacuum-assisted biopsy of microcalcifications: External validation study of a decision tree selecting patients eligible for surveillance. , 2021, European journal of radiology.

[14]  M. Mastropasqua,et al.  Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate? , 2021, Diagnostics.

[15]  G. Cicero,et al.  High-risk lesions of the breast: concurrent diagnostic tools and management recommendations , 2021, Insights into Imaging.

[16]  Nickolas Gagnon,et al.  Upgrade rate of atypical ductal hyperplasia: ten years experience and predictive factors. , 2021, The Journal of surgical research.

[17]  P. Tan,et al.  Atypical Ductal Hyperplasia of the Breast on Core Needle Biopsy: Risk of Malignant Upgrade on Surgical Excision , 2021, Journal of breast cancer.

[18]  M. Mahoney,et al.  Analysis of 612 Benign Papillomas Diagnosed At Core Biopsy: Rate of Upgrade to Malignancy, Factors Associated with Upgrade, and A Proposal For Selective Surgical Excision. , 2021, AJR. American journal of roentgenology.

[19]  J. Soares-Júnior,et al.  Core needle biopsy in fibroepithelial tumors: predicting factors for phyllodes tumors , 2021, Clinics.

[20]  O. Kearins,et al.  The impact of vacuum-assisted excision in the management of indeterminate B3 lesions in the NHS Breast Screening Programme in England. , 2021, Clinical radiology.

[21]  Jingqin Fang,et al.  Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast , 2021, Cancer Imaging.

[22]  I. Bedrosian,et al.  Risk of Breast Cancer in Selected Women With Atypical Ductal Hyperplasia Who do not Undergo Surgical Excision , 2021, Annals of surgery.

[23]  J. Kao,et al.  Atypical ductal hyperplasia on core needle biopsy: Surgical outcomes of 200 consecutive cases from a high‐volume breast program , 2021, The breast journal.

[24]  Danny F. Martinez,et al.  Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade , 2021, Breast Cancer Research and Treatment.

[25]  M. Mulligan,et al.  Upgrade Rate of Pure Flat Epithelial Atypia Diagnosed at Core Needle Biopsy: A Systematic Review and Meta-Analysis. , 2021, Radiology. Imaging cancer.

[26]  Won Hwa Kim,et al.  Artificial intelligence in breast ultrasonography , 2020, Ultrasonography.

[27]  S. Schnitt,et al.  The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034) , 2020, Annals of Surgical Oncology.

[28]  N. Sharma,et al.  Role of vacuum assisted excision in minimising overtreatment of ductal atypias. , 2020, European journal of radiology.

[29]  M. Morrow,et al.  Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia , 2020, Breast Cancer Research and Treatment.

[30]  G. Di Giulio,et al.  Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? , 2020, European Radiology.

[31]  C. Zuiani,et al.  Lesions of uncertain malignant potential of the breast (B3) on vacuum-assisted biopsy for microcalcifications: Predictors of malignancy. , 2020, European journal of radiology.

[32]  F. Flanagan,et al.  Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes , 2020, Breast Cancer Research and Treatment.

[33]  P. Tan.  Fibroepithelial lesions revisited: implications for diagnosis and management , 2020, Modern Pathology.

[34]  G. Perrone,et al.  Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential , 2020, Tumori.

[35]  T. Rau,et al.  Inter-observer reproducibility of classical lobular neoplasia (B3 lesions) in preoperative breast biopsies: a study of the Swiss Working Group of breast and gynecopathologists , 2020, Journal of Cancer Research and Clinical Oncology.

[36]  T. Helbich,et al.  Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging. , 2020 .

[37]  T. Helbich,et al.  Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging , 2020, Insights into Imaging.

[38]  A. Lewin,et al.  Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines. , 2019, AJR. American journal of roentgenology.

[39]  N. Houssami,et al.  Preoperative breast cancer staging with multi-modality imaging and surgical outcomes. , 2019, European journal of radiology.

[40]  R. Kubik-Huch,et al.  Stereotactic Vacuum-Assisted Breast Biopsy in Ductal Carcinoma in situ: Residual Microcalcifications and Intraoperative Findings , 2019, Breast Care.

[41]  B. Zobel,et al.  Our Radiological Experience on B3 Lesions: Correlation Between Mammographic and MRI Findings With Histologic Definitive Result. , 2019, Clinical breast cancer.

[42]  R. Wasan,et al.  An audit of mammographic screen detected lesions of uncertain malignant potential (B3) diagnosed on initial image guided needle biopsy: how has our practice changed over 10 years? , 2019, Clinical radiology.

[43]  P. Williams,et al.  Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with malignancy on surgical excision , 2019, Virchows Archiv.

[44]  F. Beca,et al.  Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study , 2019, Journal of Clinical Pathology.

[45]  G. Tozbikian,et al.  Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade rates , 2019, Diagnostic Pathology.

[46]  Anna I. Holbrook,et al.  Triaging Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Percutaneous Core Biopsy to Surgery or Observation: Assiduous Radiologic-Pathologic Correlation Works, Quantitating Extent of Disease Does Not. , 2019, Archives of pathology & laboratory medicine.

[47]  M. Twiddy,et al.  High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[48]  J. Darbinian,et al.  Benign Papillary Breast Mass Lesions: Favorable Outcomes with Surgical Excision or Imaging Surveillance , 2019, Annals of Surgical Oncology.

[49]  Z. Varga,et al.  Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens , 2018, Breast Cancer.

[50]  E. Morris,et al.  Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) , 2018, Breast Cancer Research and Treatment.

[51]  G. Farshid,et al.  Meta-analysis of upgrade rates in 3163 radial scars excised after needle core biopsy diagnosis , 2018, Breast Cancer Research and Treatment.

[52]  S. Pinder,et al.  NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). , 2018, Clinical radiology.

[53]  R. Aft,et al.  Radial scar on image-guided breast biopsy: is surgical excision necessary? , 2018, Breast Cancer Research and Treatment.

[54]  D. Treanor,et al.  Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology , 2018, Journal of Clinical Pathology.

[55]  G. Tse,et al.  Mammary phyllodes tumour: a 15-year multicentre clinical review , 2017, Journal of Clinical Pathology.

[56]  C. Kuhl.  Abbreviated breast MRI for screening women with dense breast: the EA1141 trial , 2017, The British journal of radiology.

[57]  M. Newell,et al.  Radial Scars of the Breast Encountered at Core Biopsy: Review of Histologic, Imaging, and Management Considerations. , 2017, AJR. American journal of roentgenology.

[58]  M. Shaaban,et al.  Benign phyllodes tumours of the breast: (Over) treatment of margins - A literature review. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[59]  Robert T. Fazzio,et al.  Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia , 2017, Breast Cancer Research and Treatment.

[60]  Zhi-rui Zhou,et al.  Diagnostic performance of core needle biopsy in identifying breast phyllodes tumors. , 2016, Journal of thoracic disease.

[61]  Zhi-rui Zhou,et al.  Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence. , 2016, Journal of thoracic disease.

[62]  S. Pinder,et al.  The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project. , 2016, Breast.

[63]  F. Su,et al.  Benign Phyllodes Tumor of the Breast Diagnosed After Ultrasound-Guided Vacuum-Assisted Biopsy: Surgical Excision or Wait-and-Watch? , 2016, Annals of Surgical Oncology.

[64]  K. Horgan,et al.  Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice? , 2015, Journal of Clinical Pathology.

[65]  J. Youk,et al.  Phyllodes tumor diagnosed after ultrasound-guided vacuum-assisted excision: should it be followed by surgical excision? , 2015, Ultrasound in medicine & biology.

[66]  Donoghue,et al.  Phyllodes tumours of the breast: radiological presentation, management and follow-up. , 2014, The British journal of radiology.

[67]  P. Argani,et al.  Interobserver Variability by Pathologists in the Distinction Between Cellular Fibroadenomas and Phyllodes Tumors , 2014, International journal of surgical pathology.

[68]  L. von Karsa,et al.  Development and implementation of guidelines for quality assurance in breast cancer screening: the European experience. , 2013, Salud publica de Mexico.

[69]  S. Meterissian,et al.  Flat epithelial atypia of the breast: pathological-radiological correlation. , 2011, AJR. American journal of roentgenology.

[70]  P. Skaane,et al.  MRI features of intraductal papilloma of the breast: sheep in wolf's clothing? , 2011, Acta radiologica.

[71]  E. S. de Paredes,et al.  Columnar cell lesions of the breast: mammographic findings with histopathologic correlation. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[72]  C. Metcalf,et al.  Ultrasound imaging features of radial scars of the breast. , 2007, Australasian radiology.

[73]  I. Ellis,et al.  Best Practice No 179 , 2004, Journal of Clinical Pathology.

[74]  F. Tavassoli,et al.  A comparison of the results of long‐term follow‐up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast , 1990, Cancer.

[75]  W. Dupont,et al.  Atypical hyperplastic lesions of the female breast: A long-term follow-up study , 1986 .

[76]  H. Hamperl.  [Radial scars (scarring) and obliterating mastopathy (author's transl)]. , 1975, Virchows Archiv. A, Pathological anatomy and histology.

[77]  F. Sardanelli,et al.  Upgrade Rate of Percutaneously Diagnosed Pure Atypical Ductal Hyperplasia: Systematic Review and Meta-Analysis of 6458 Lesions. , 2019, Radiology.

[78]  J. Ruterbusch,et al.  Can problematic fibroepithelial lesions be accurately classified on core needle biopsies? , 2016, Human pathology.

[79]  L. Hartmann,et al.  Atypical hyperplasia of the breast--risk assessment and management options. , 2015, The New England journal of medicine.

[80]  Consumer Protection,et al.  European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.